91 related articles for article (PubMed ID: 12429654)
1. Vasculogenesis Plays a Role in the Growth of Ewing's Sarcoma in Vivo.
Bolontrade MF; Zhou RR; Kleinerman ES
Clin Cancer Res; 2002 Nov; 8(11):3622-7. PubMed ID: 12429654
[TBL] [Abstract][Full Text] [Related]
2. Vasculogenesis driven by bone marrow-derived cells is essential for growth of Ewing's sarcomas.
Yu L; Su B; Hollomon M; Deng Y; Facchinetti V; Kleinerman ES
Cancer Res; 2010 Feb; 70(4):1334-43. PubMed ID: 20124484
[TBL] [Abstract][Full Text] [Related]
3. VEGF165 expression in the tumor microenvironment influences the differentiation of bone marrow-derived pericytes that contribute to the Ewing's sarcoma vasculature.
Reddy K; Cao Y; Zhou Z; Yu L; Jia SF; Kleinerman ES
Angiogenesis; 2008; 11(3):257-67. PubMed ID: 18344025
[TBL] [Abstract][Full Text] [Related]
4. Delta-like ligand 4 plays a critical role in pericyte/vascular smooth muscle cell formation during vasculogenesis and tumor vessel expansion in Ewing's sarcoma.
Schadler KL; Zweidler-McKay PA; Guan H; Kleinerman ES
Clin Cancer Res; 2010 Feb; 16(3):848-56. PubMed ID: 20103680
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow subsets differentiate into endothelial cells and pericytes contributing to Ewing's tumor vessels.
Reddy K; Zhou Z; Schadler K; Jia SF; Kleinerman ES
Mol Cancer Res; 2008 Jun; 6(6):929-36. PubMed ID: 18567797
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow cells participate in tumor vessel formation that supports the growth of Ewing's sarcoma in the lung.
Zhou Z; Stewart KS; Yu L; Kleinerman ES
Angiogenesis; 2011 May; 14(2):125-33. PubMed ID: 21184173
[TBL] [Abstract][Full Text] [Related]
7. Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.
Reddy K; Zhou Z; Jia SF; Lee TH; Morales-Arias J; Cao Y; Kleinerman ES
Int J Cancer; 2008 Aug; 123(4):831-7. PubMed ID: 18537159
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Ewing's sarcoma tumor growth, tumor vessel formation, and vasculogenesis following anti vascular endothelial growth factor receptor-2 therapy.
Zhou Z; Bolontrade MF; Reddy K; Duan X; Guan H; Yu L; Hicklin DJ; Kleinerman ES
Clin Cancer Res; 2007 Aug; 13(16):4867-73. PubMed ID: 17699866
[TBL] [Abstract][Full Text] [Related]
9. Production of VEGF165 by Ewing's sarcoma cells induces vasculogenesis and the incorporation of CD34+ stem cells into the expanding tumor vasculature.
Lee TH; Bolontrade MF; Worth LL; Guan H; Ellis LM; Kleinerman ES
Int J Cancer; 2006 Aug; 119(4):839-46. PubMed ID: 16557578
[TBL] [Abstract][Full Text] [Related]
10. [The immunogistochemical aspects of the angiogenesis by Ewing's sarcoma].
Akhundov ÉD; Muradov KhK; Alieva IO; Sadykhova GG
Khirurgiia (Mosk); 2011; (11):41-4. PubMed ID: 22408800
[TBL] [Abstract][Full Text] [Related]
11. EGFR inhibition fails to suppress vascular proliferation and tumor growth in a Ewing's sarcoma model.
Chernoguz A; Crawford K; Donovan E; Vandersall A; Berglund C; Cripe TP; Frischer JS
J Surg Res; 2012 Mar; 173(1):1-9. PubMed ID: 21658718
[TBL] [Abstract][Full Text] [Related]
12. VEGF(165), but not VEGF(189), stimulates vasculogenesis and bone marrow cell migration into Ewing's sarcoma tumors in vivo.
Zhou Z; Reddy K; Guan H; Kleinerman ES
Mol Cancer Res; 2007 Nov; 5(11):1125-32. PubMed ID: 18025258
[TBL] [Abstract][Full Text] [Related]
13. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
[TBL] [Abstract][Full Text] [Related]
14. Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: quantitation by real-time polymerase chain reaction.
Merino ME; Navid F; Christensen BL; Toretsky JA; Helman LJ; Cheung NK; Mackall CL
J Clin Oncol; 2001 Aug; 19(16):3649-59. PubMed ID: 11504746
[TBL] [Abstract][Full Text] [Related]
15. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.
Yang Y; Li H; Zhang F; Shi H; Zhen T; Dai S; Kang L; Liang Y; Wang J; Han A
J Pathol; 2013 Nov; 231(3):323-34. PubMed ID: 23878072
[TBL] [Abstract][Full Text] [Related]
17. Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas.
Machein MR; Renninger S; de Lima-Hahn E; Plate KH
Brain Pathol; 2003 Oct; 13(4):582-97. PubMed ID: 14655762
[TBL] [Abstract][Full Text] [Related]
18. Neovascularization in Ewing's sarcoma.
Mavrogenis AF; Vottis CT; Megaloikonomos PD; Agrogiannis GD; Theocharis S
Neoplasma; 2018 Mar; 65(3):317-325. PubMed ID: 29788734
[TBL] [Abstract][Full Text] [Related]
19. Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.
Sturla LM; Westwood G; Selby PJ; Lewis IJ; Burchill SA
Cancer Res; 2000 Nov; 60(21):6160-70. PubMed ID: 11085540
[TBL] [Abstract][Full Text] [Related]
20. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.
Seon BK; Matsuno F; Haruta Y; Kondo M; Barcos M
Clin Cancer Res; 1997 Jul; 3(7):1031-44. PubMed ID: 9815781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]